American Gene Technologies®
In The News
Life Sciences Voice: Why Focus on Treating Diseases Instead of Curing Them?
Original Post on lifescivoice.com and written by: Jeff Galvin It’s a tragic irony: So much money has been poured into treating diseases, but far less into actually curing them. The pharmaceutical industry has done an incredible job of developing highly profitable treatments for a wide…
Read More
Dna Weekly: Accelerate Drug Development And Novel Therapeutics With American Gene Technologies
Original Post on DNAWeekly and written by: Ditsa Keren American Gene Technologies (AGT) is a cutting-edge biotechnology company creating technologies that speed up the development of cures and treatments in the emerging field of gene therapy. In this interview, founder and CEO Jeff Galvin pinpoints the current challenges…
Read More
How A Disconnected Biohealth Ecosystem Became The Next Big Thing
Subscribe to our YouTube Channel Jeff Galvin, CEO of American Gene Technologies and Rich Bendis, CEO and President of BioHealth Innovation, Inc. have a fireside chat about the rapid evolution of the BioHealth Capital Region. On the heels of Silicon Valley’s branding as one of…
Read More
WUSA9: This local company is creating the cure for HIV. Here’s when it could be available to all.
[This webpage is not searchable via search engines out of respect for the original publisher who owns the content. This copy is only rendered here for AGT readers]. Published on: WUSA9 | BY Lorenzo Hall Published: 5:18 PM EDT July 5, 2021 American Gene Technologies is celebrating…
Read More
Global Life Science and Pharmaceutical Headhunter Mantell Associates Network Interviews CEO Jeff Galvin
Subscribe to our YouTube Channel Mantell Associates Network interviews Jeff Galvin, CEO and Founder of American Gene Technologies™ (AGT) for its global Podcast listeners. In this interview, Galvin shares the company’s cell and gene therapy technology, toolset, and vision. Looking forward, host Alessandro Mantell and…
Read More
Jeff Galvin at BIO International Convention Digital 2021
Subscribe to our YouTube Channel Jeff Galvin, CEO of American Gene Technologies, presents AGT’s latest news at the BIO Digital International Convention 2021. As the first patient in AGT’s Phase 1 clinical trial is infused with AGT103-T, an autologous cell therapy intended to cure HIV,…
Read More
ABC 7 News Live Segment by Justin Hinton
Subscribe to our YouTube Channel [This page is not searchable via search engines out of respect for the original publisher who owns the content. This copy is only rendered here for AGT readers]. ABC7 WJLA Report by Justin Hinton Reports on May 26th 2021…
Read More
“Curing Incurable Diseases with Jeff Galvin” | Lab to Launch Podcast by Qualio
Listen on any major podcast player From Lab to Launch by Qualio: “What if incurable diseases like HIV, cancer, PKU, and epithelial solid tumors were completely curable? We’re closer than you might think. Really close. In fact, Jeff Galvin and his team at American Gene…
Read More
How the Life Sciences Industry is Changing the World – “This Is USG” Video Podcast | Episode 15
Subscribe to our YouTube Channel In this episode, Dr. Anne Khademian is joined by Jeff Galvin, CEO of American Gene Technologies, for a conversation about the life sciences industry and how it is changing the world with life-saving cures, treatments and technologies to improve health…
Read More
AGT Named “Breakthrough Company of the Year” Award Winner by Biobuzz
Award Sponsor: CRB This award recognizes the entrepreneurs and startup companies that have achieved strong commercialization momentum behind their innovative technology. Startups fuel the innovation engine in the region and reflect the future growth of any ecosystem. Nominees were selected from companies that showed the most…
Read MoreSubscribe to News Releases and News Updates
Subscribe to our news release and published article updates to be notified when we release new content!
Follow AGT on Social Media
AGT on Facebook
